These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 38637540)

  • 21. Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy.
    Rauf A; Joshi PB; Olatunde A; Hafeez N; Ahmad Z; Hemeg HA; Aljohani ASM; Al Abdulmonem W; Thiruvengadam M; Viswanathan D; Rajakumar G; Thiruvengadam R
    Med Oncol; 2024 Apr; 41(5):122. PubMed ID: 38652344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Old wine in new bottles: Drug repurposing in oncology.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining repurposed drugs to treat colorectal cancer.
    Duarte D; Vale N
    Drug Discov Today; 2022 Jan; 27(1):165-184. PubMed ID: 34592446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
    Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment.
    Sousa SM; Xavier CPR; Vasconcelos MH; Palmeira A
    Curr Top Med Chem; 2023; 23(13):1171-1195. PubMed ID: 36717997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug repurposing for cancer.
    Banerjee J; Tiwari AK; Banerjee S
    Prog Mol Biol Transl Sci; 2024; 207():123-150. PubMed ID: 38942535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
    Islam S; Wang S; Bowden N; Martin J; Head R
    Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug rechanneling: A novel paradigm for cancer treatment.
    Kaushik I; Ramachandran S; Prasad S; Srivastava SK
    Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches of pre-clinical and clinical trials of repurposed drug.
    Israr J; Alam S; Kumar A
    Prog Mol Biol Transl Sci; 2024; 205():259-275. PubMed ID: 38789183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current state and future perspective of drug repurposing in malignant glioma.
    Siegelin MD; Schneider E; Westhoff MA; Wirtz CR; Karpel-Massler G
    Semin Cancer Biol; 2021 Jan; 68():92-104. PubMed ID: 31734137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. System biology approaches for drug repurposing.
    Israr J; Alam S; Kumar A
    Prog Mol Biol Transl Sci; 2024; 205():221-245. PubMed ID: 38789180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerating space radiation countermeasure development through drug repurposing.
    Madrid PB; Chang PY
    Life Sci Space Res (Amst); 2022 Nov; 35():30-35. PubMed ID: 36336366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
    Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of Drug Repurposing-Based Precision Medicine Platform for Leukaemia Patient Treatment.
    Kenmogne VL; Nweke EE; Takundwa MM; Fru PN; Thimiri Govinda Raj DB
    Adv Exp Med Biol; 2023; 1410():115-126. PubMed ID: 36289161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repurposing drugs targeting metabolic diseases for cancer therapeutics.
    Pillai U J; Ray A; Maan M; Dutta M
    Drug Discov Today; 2023 Sep; 28(9):103684. PubMed ID: 37379903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
    Thilakasiri PS; Dmello RS; Nero TL; Parker MW; Ernst M; Chand AL
    Semin Cancer Biol; 2021 Jan; 68():31-46. PubMed ID: 31711994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergizing drug repurposing and target identification for neurodegenerative diseases.
    Sahu M; Vashishth S; Kukreti N; Gulia A; Russell A; Ambasta RK; Kumar P
    Prog Mol Biol Transl Sci; 2024; 205():111-169. PubMed ID: 38789177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing of approved cardiovascular drugs.
    Ishida J; Konishi M; Ebner N; Springer J
    J Transl Med; 2016 Sep; 14():269. PubMed ID: 27646033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
    Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
    Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repurposing old drugs to fight multidrug resistant cancers.
    Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
    Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.